🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-11-25
Trial ID
NCT06613100
Treatments Being Tested
The primary objective of this study is to compare overall survival (OS) in ...
Status
Recruiting
Location
City of Hope Cancer Center Phoenix
Start Date
2025-11-28
Trial ID
NCT07213674
Treatments Being Tested
This is a phase 2a, open label, single arm, multi-site study of xaluritamig...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10
Trial ID
NCT07737925
Treatments Being Tested
The primary objective of this trial is to determine the safety profile of x...
Status
Recruiting
Location
Rocky Mountain Cancer Centers
Start Date
2026-04-28
Trial ID
NCT07493512
Treatments Being Tested
The main objective of the trial is to evaluate the safety and tolerability ...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-10-07
Trial ID
NCT07140900
Treatments Being Tested
The main objective of this study is to evaluate the safety and tolerability...
Status
Active Not Recruiting
Location
University of Minnesota Medical Center Fairview
Start Date
2024-09-23
Trial ID
NCT06555796
Treatments Being Tested
The main objectives of this trial are to determine the recommended dose for...
Status
Recruiting
Location
Cedars Sinai Medical Center
Start Date
2026-04-08
Trial ID
NCT07297979
Treatments Being Tested
The main objective of the study is to compare overall survival in participa...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2024-12-09
Trial ID
NCT06691984
Treatments Being Tested